Clinical Trials
10 trialsNCT06930846 2025-11-21
HOBSCOTCH-CA
Dartmouth-Hitchcock Medical Center
Phase NA Recruiting
NCT06051240 2024-04-12
LiBRA
Region Stockholm
Phase 2 Recruiting
NCT02822573 2023-09-13
Remember
Wake Forest University Health Sciences
Phase 3 Completed
NCT05523115 2022-11-08
An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits
Heights
Phase NA Completed
NCT03661034 2021-08-24
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Cognito Therapeutics, Inc.
Phase NA Unknown
NCT03420105 2020-03-09
PROSOM-K
Centre Francois Baclesse
Phase NA Completed
NCT01151670 2018-08-01
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Wake Forest University Health Sciences
Phase 1 Completed
NCT01217996 2014-04-29
Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors
St. Jude Children's Research Hospital
Phase NA Completed
NCT00387062 2008-06-24
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
Posit Science Corporation
Phase 1 Completed
NCT00047476 2005-06-24
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
Celgene
Phase 2 Completed